Yale Researchers Identify New Post-Vaccination Syndrome Linked to COVID-19 Vaccines

Yale University researchers have identified a concerning condition known as 'post-vaccination syndrome' (PVS) associated with mRNA COVID-19 vaccines, characterized by symptoms such as brain fog, dizziness, and exercise intolerance. The study, led by Dr. Akiko Iwasaki, found distinct immune cell changes in patients with PVS, including lower levels of effector CD4 T cells and elevated levels of CD8 T cells that secrete tumor necrosis factor. Notably, some patients exhibited circulating coronavirus proteins long after vaccination, raising questions about the potential long-term effects of the vaccines. Additionally, the syndrome appears to reactivate the Epstein-Barr virus, which is linked to various health issues. While the findings are still preliminary and have not been peer-reviewed, they underscore the need for further research to determine the prevalence and risk factors associated with PVS. Experts stress the importance of ongoing monitoring to understand the mechanisms behind these vaccine-associated effects.